Mo u may be correct from a sensitivity pov, but the moment

New Post Public Reply Private Reply Replies (0) Message Board
retired pharma Mo #70468
640
Mo u may be correct from a sensitivity pov, but the moment Shawn Wolfe went onto a Public Forum where he's previously posted his Business and Personal opinions including BUS PHONE NUMBERS and gave an ACCOUNTING of either himself or his Mother as becoming sick with Covid-19 he became a person who is under the microscope to validate what hes posted.

I personally will not call him and ask him questions about the drug and quite Honestly like you requested I hope NO ONE does, but the cats out of the bag on BRIL! There are forces working to KILL this DRUG!

We are Blessed that its been studied at major Universities now like GMU, that DOD through BARDA are now in play..thats opened its evaluation up and should protect it going forward! At this point we are DATA DRIVEN and pending....

I personally have posted about BRIL on my own FB account...my posts are in regards to the FDA sitting on this drug, when they know the data is good and at the same time our Government is MANDATING VACCINES and "reporting + tests" as a record on all US citizens. Im troubled that Congress has a spending bill for $3.2Trillion and Ive seen NO $$$ earmarked to support IPIX to help them along w/ a DRUG THAT SAVES LIVES, all along the same FEDS can allocate money for TREES and BRIDGES TO NOWHERE...

Having worked 33 years in Big Pharma I have no love lost for FDA..they have FAILED us many times over the years...if any org of the Federal Government can screw up BRIL, an NDA..a right to try initiative it will be our own FDA...former head of FDA Gottleib has written a book about it...https://www.msn.com/en-us/news/us/former-fda-commissioner-we-remain-almost-equally-vulnerable-to-threat-from-the-next-pandemic/ar-AAOt6Q6...the Feds are very POLITICAL over Covid and have BLOWN IT BADLY...in fact they take $$$ from Big Pharma to "approve" their applications at the expense of small Cos like IPIX...this happens regularly!

We may have an advantage this time around based on previous History of the drug, and the fact that DOD/BARDA potentially imo is involved w/ this drug!

What concerns me the most is that Government agencies seem more VACCINE ORIENTED as apposed to TREATMENT oriented!

I worry that our great little drug BRIL could be DERAILED by a Big Pharma (or an FDA official from INSIDE)...who is working w/ the FDA on their own Treatments a la PFIZER as an example.I Can tell you all the LOBBY ISTS in DC are working hard to push VACCINES only and the Feds want to MANDATE THEM. NEW TREATMENTs ARE EXPENSIVE...Vaccines are not...Im NOT an anti-vaxer.. I believe in choice.I know Docs in DC who swear by Hydroxychoroquine at HIGH DOSE early on in OP treatment in Covid and the FDA has SHUT IT DOWN! We have major Hospital Groups like Henry Ford in Detroit that SWEAR BY HYDROXY as a good working repurposed med..it cost PENNIES a day...thats the issue...no $$$ to support it..thats the rub..thats big pharma influence!

They(the FEDS) do not support docs and OFF LABEL USE and REPURPOSing meds...I have posted already about anti-PDE4 and Hydroxychloroquine where that MOA and HIGH DOSE is likely why it works even though the drug is an AntiParasitic, through a strong Compliment Cascade effect!

The FDA and Dr Fauci and CDC and many others have Totally squelched this application of Hydroxychoroquine and in my mind that supports my argument!

We will likely be ok...but the risks and politics are against us!

If the Feds wanted to CURE THIS VIRUS they had in their power to do so many months ago! Thats why I believe WE SHOULD PUSH BACK HARD NOW..get the word out to all MEDIA..expose the TRUTH as we know it.

That being said, I mostly agree with you that we should not bother the Shawn Wolfes of this World! But we also should not TRUST the Feds to do the right thing!

GLTA longs!

RP


2

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lincoln's Legal Tangle: Stock Plunge Sparks Lawsuit

Updated Category News Views 0

Lincoln Educational's Troubles Unravel You think you've seen it all, then boom—Lincoln Educational Services hit the skids with their stock diving close to 25% back in August 2026. This ain't your usual small hiccup; we’re talking a lawsuit filed and investors eyeing action as miserly as a broker when the market tumbles. News like this? It shakes the rafters of any...

Continue Reading
AI Agents Race: 10M Downloads Spark Competitive Fire

Updated Category News Views 3

The AI Agent Arms Race is On Throwdown time in the AI jungle, folks. A new AI agent hit the big 10.9 million downloads in a mere six weeks. In the digital world, those kinds of numbers are the equivalent of finding a unicorn in your backyard. This data gem comes courtesy of Sensor Tower, as reported by Yahoo Finance, and it looks like the appetite for this technological...

Continue Reading
Florida Leaders Set Sights on Top 10 Economy by 2030

Updated Category News Views 10

Florida's Ambitious Economic Goals When someone floats the idea of a state's economy cracking the top 10 globally by the year 2030, you've got to wonder if it's all sunshine and rainbows, or if there's some serious groundwork being laid. The Florida Chamber Foundation seems to think it's achievable. As the end of October rolls around, they're throwing the 2026 Future of...

Continue Reading
Software Tax Hits Enterprises: Costly Control Concerns

Updated Category News Views 4

Unanticipated Software Costs: Who's in Charge? Picture this: you're running a tech setup at a major corporation, but the software changes thrust upon you aren't anything you would've chosen freely. Yeah, that's about one in four dollars from your hot little budget spent on tweaks and adjustments you didn’t ask for. And it's not as glamorous as it sounds—more like a...

Continue Reading
Cruise Planners Sets AI Benchmark in Travel Innovs

Updated Category News Views 16

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Continue Reading
IBM Backs Leena AI: Shaping Enterprise Automation

Updated Category News Views 8

IBM's Strategic Bet on Enterprise Automation Diving into the blazing 2026 market, IBM Ventures has thrown its weight behind Leena AI, an enterprise agentic AI firm that's out to shake things up. You see, the name of the game isn't just flashy AI chatbots anymore. Companies like Leena AI are setting their sights on the back-office grunt work—the lifeblood operations in...

Continue Reading
Ryan Stills: Vegan Powerlifter Defies Odds, Wins Sixth World Title

Updated Category News Views 16

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Continue Reading
Ruth E. Carter Returns Home with Celebrated Exhibition

Updated Category News Views 12

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Continue Reading
OSV Talks Launches New Season on Ministry Growth

Updated Category News Views 4

A Fresh Wave of Ideas for Catholic Ministry Some topics never go out of style, and it looks like the crew at OSV is banking on that with their latest salvo of OSV Talks. With themes ranging from peacemaking to AI, they're tossing it all against the spiritual wall, hoping it sticks. The comeback of their video series has that classic 'get your act together' vibe we all...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 11

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading

Top 5 Most Recently Viewed Articles

United Warehouse Partners for Sustainable Solar Energy Growth

Updated Category News Views 107

United Warehouse Advances Sustainability with New Solar Agreement United Warehouse Limited, a subsidiary of Marvion Inc. (OTC: MVNC), has made significant strides in its commitment to sustainability and the diversification of revenue streams. Recently, the company entered into a new Solar Photovoltaic (PV) System Service Agreement with Starwarehouse Engineering Limited....

Continue Reading
Tigo Energy to Innovate with Brazil's Largest Floating Solar Plant

Updated Category News Views 84

Tigo Energy to Innovate with Brazil's Largest Floating Solar Plant Tigo Energy, Inc. (NASDAQ: TYGO), a frontrunner in intelligent solar and energy software solutions, is making strides in renewable energy by partnering with solar development firm Apollo Flutuantes. This collaboration will lead to the deployment of 97,200 advanced Tigo optimizers in Brazil's largest...

Continue Reading
Antengene Signs Lucrative Deal with K2 for ATG-106

Updated Category News Views 31

Antengene and K2 Therapeutics Join Forces Antengene is not playing around, showing once again they've got a knack for sniffing out lucrative opportunities. This time, they've inked a deal with K2 Therapeutics centered around ATG-106, a first-of-its-kind CDH6 x CD3 bispecific T cell engager (TCE). We're talking a solid preclinical asset poised to take on solid tumors. This...

Continue Reading
Earnings Outlook for PagerDuty: What To Expect This Quarter

Updated Category News Views 155

Overview of PagerDuty's Upcoming Earnings PagerDuty (NYSE: PD) is set to announce its quarterly earnings shortly. Investors are keenly awaiting this announcement, sparking curiosity and speculation about the company's performance in the recent quarter. As the excitement builds, it's essential to break down what analysts are predicting and what investors can expect once...

Continue Reading
AllianceBernstein Funds Reveal New Exciting Distribution Rates

Updated Category News Views 133

AllianceBernstein Funds Promote Distribution Updates The AllianceBernstein Closed-End Funds have announced significant distribution rates today, bringing fresh news to investors. This update is set to influence future investment decisions within the fund community. Details of Distribution Rates Announced Distributions The distributions rates made public include critical...

Continue Reading